TitleQuality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis
AuthorsLin, Letao
Ma, Haocheng
Wang, Jian
Guan, Haitao
Yang, Min
Tong, Xiaoqiang
Zou, Yinghua
AffiliationPeking Univ, Dept Intervent Radiol & Vasc Surg, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China
KeywordsLaparoscopic radiofrequency ablation
Meta-analysis
Quality of life
Symptomatic uterine fibroid
Issue Date2019
PublisherJOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
AbstractIn this review, we assessed the short-term (3 and 6 months) and long-term (12, 24, and 36 months) symptom relief and quality of life improvement, procedure-related adverse event rate, reintervention rate, and days missed from work after laparoscopic radiofrequency ablation. Using MeSH keywords "uterine fibroid" and "ablation technique," a systematic search was performed in PubMed, Ovid, Embase, Cochrane Library, and Clinicaltrials.gov. Studies consisting of uterine fibroid symptoms and quality of life scores were considered eligible. Both comparative and non-comparative studies were included. Using a random-effects model, a meta-analysis was performed. Eight studies with a total of 581 patients were finally included in our review. Based on validated questionnaires, quality of life improved significantly until 36 months after laparoscopic radiofrequency ablation therapy, with a maximum improvement (Health-Related Quality of Life [HRQL] questionnaire score of +41.64 [95% confidence interval (CI), 38.94-44.34] and a transformed Symptom Severity Score [tSSS] of -39.37 [95% CI, 34.70-44.04]) at 12 months after laparoscopic radiofrequency ablation. All subscales of quality of life improved significantly, and most of the changes remained stable in long-term follow-up. The overall reintervention rate was 4.39% (95% CI, 1.60%-8.45%), and the median uterine volume reduction was 69.17 cm(3) (95% CI, 35.87-102.46 cm 3). The overall procedure- related adverse events rate was 1.78% (95% CI, 0.62%-3.53%), and patients missed an average of 4.35 days (95% CI, 2.55-6.15 days) of work. In conclusion, laparoscopic radiofrequency ablation therapy is an efficacious way to treat small-sized and nonpedunculated symptomatic uterine fibroids, providing stable long-term symptom relief and quality of life improvement with a low risk of adverse events and reintervention and just a few days of missed work. (C) 2018 AAGL. All rights reserved.
URIhttp://hdl.handle.net/20.500.11897/550351
ISSN1553-4650
DOI10.1016/j.jmig.2018.09.772
IndexedSCI(E)
Appears in Collections:第一医院

Files in This Work
There are no files associated with this item.

Web of Science®



Checked on Last Week

Scopus®



Checked on Current Time

百度学术™



Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.